Company: NIVFW
Filing Date: 2025-05-01
Form Type: F-1/A
Source: 0001213900-25-038045
Chunk: 125

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-01
Form: F-1/A
Chunk 125
---
 clinical outcomes for NewGenIvf   
 by achieving a higher implantation rate of 70.9% and reducing miscarriage rates by 26.6%.                                           |

| ● | Next-Generation Sequencing (“NGS”): NGS is a high-throughput                                                                             
 technology for determining the sequence of deoxyribonucleic acid (“DNA”) or ribonucleic acid (“RNA”) to study                            
 genetic variation associated with diseases or other biological phenomena. NGS determines the sequence of a sample all at once by         
 using parallel sequencing. Traditional Sanger sequencing determines the sequence of a sample one section at a time. Sequencing thousands 
 of gene fragments simultaneously with NGS reduces time and cost associated with sequencing and increases the coverage quality and        
 data output.                                                                                                                             |

| ● | Preimplantation Genetic Diagnosis (“PGD”): Similar                                                                                    
 to PGS, PGD is also used in parallel with an IVF treatment cycle. But PGD is a process more enhanced than PGS since it scans for      
 individual genes. PGD is the practice of evaluating embryos for specific genetic abnormalities, such as sickle cell disease or cystic 
 fibrosis, where carrier status has been documented in each of the parents. By using this technique, physicians are able to check      
 the genes or chromosomes for a specific genetic condition. PGD can decrease the risk of miscarriage and this technology can help      
 women better achieve a healthy pregnancy. Individuals who suspect or know they carry genes for serious medical conditions may opt     
 to screen for healthy embryos ahead of time.                                                                                          |

79 Well Established Brand with Reliable Reputation The founders of NewGenIvf entered the fertility market as agents in 2011 by introducing patients in need to a Thailand clinic for fertility treatments. The founders of NewGenIvf started to operate their own clinic in Thailand in 2014 and subsequently added clinics in Cambodia and Kyrgyzstan. Since then, NewGenIvf has attracted clients from countries throughout Asia-Pacific, including Mainland China, Hong Kong, India, Thailand, Australia and Taiwan. NewGenIvf benefits from the favourable geographic locations of its clinics, especially its clinic in Thailand. Located in central Bangkok and situated in one of the biggest shopping malls of the city, the clinic is located in close proximity to various transportation facilities and popular tourist attractions, such as the Erawan Shrine. In this regard, NewGenIvf believes that its business has benefited from, and will continue to benefit from, the convenience of its locations. NewGenI